Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates
29/3 00:25
Arcadia Biosciences (RKDA) came out with a quarterly loss of $2.48 per share versus the Zacks Consensus Estimate of a loss of $2.68. This compares to loss of $6.31 per share a year ago. These figures are adjusted for non-recurring...